Synlab has followed through on rumours it was divesting its non-core business by selling its Analytics & Services business for €500m. It says the proceeds will stay in the group for future use.
Munich Leukaemia Laboratory (MLL), a specialist founder-owned lab in Germany, is for sale with a potential €480m price tag. A source says it's one of the "most modern genetics labs" in the world and is likely to sell to one of the large lab groups.
The Polish national payor has recommended that electives be delayed to reduce the risk of COVID-19 infections. HBI hears that after a good summer of business people are again starting to avoid physical care. That could plunge the market back into the dark months of lockdown, which saw one operator considering firing 70% of its staff.
Veritas Intercontinental, the spin-off of US genome sequencing group, Veritas Genetics, has raised €5m from existing investors to help finish building a new lab in Spain. CEO Javier de Echevarría tells HBI that the money will help to establish its independence from its former parent company which temporarily ceased US trading last year.
HBI hears Synlab's private equity owner Cinven has mandated banks for an initial public offering, expected to take place next year. It will value Synlab at €5bn-6bn.
HBI speaks exclusively to George Spanos, chairman and CEO of Greece's largest primary care and diagnostic chain, about the company's plans for the future and whether rumours the company might be for sale are true.
Africa needs to come together to find a solution to the COVID crisis, which has proved to be as much an economic one as a healthcare one - and cannot and should not rely on help from outside. This was the view of an expert panel which convened online to discuss COVID-19, healthcare more generally, and African economics.
A health crisis leading to an economic downturn and a political crisis. Here is a case study of how COVID has hit Liberia based on the view of Gyude Moore, senior policy fellow at the Centre for Global Development, and former Minister of Public Work speaking on Saturday (October 10).
HBI Intelligence is now forecasting that most European lab markets will be larger in 2020, than our pre-Covid forecasts. That is despite deep dips in March and April, with some groups thinking about firing two-thirds of their staff and defaulting on rent.
Unilabs has a new chief innovation officer who comes from recently acquired Dutch lab Saltro. Dr Esther Talboom-Kamp tells HBI about the consumer-facing and B2C platforms that she built there, but the pan-European lab group is coy about what it's now building in the space.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
